Clinical Trial Update: Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy of Pegylated Interferon alone in adults with acute hepatitis C in Egypt has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED